These results suggest that high expression of IDO-1 (except in skin melanoma) and TDO-2 werse often associated with worse prognosis, while high expression of IDO-2 was often associated with better prognosis (with a few exceptions). The gene discussed is IDO2; the disease is cutaneous melanoma.